Use of pharmaceutical nanotechnology for the treatment of leishmaniasis
AUTOR(ES)
Marques, Carine Santana Ferreira
FONTE
Rev. Soc. Bras. Med. Trop.
DATA DE PUBLICAÇÃO
11/04/2019
RESUMO
Abstract INTRODUCTION: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. METHODS: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis. RESULTS: Our findings revealed a stable number of patents and scientific articles published over the past five years. CONCLUSIONS: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.
Documentos Relacionados
- EMPREENDEDORISMO E NANOTECNOLOGIA FARMACÊUTICA
- On the use of nanotechnology-based strategies for association of complex matrices from plant extracts
- Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia
- Use of the polymerase chain reaction for the diagnosis of American tegumentary leishmaniasis
- Nanotechnology for the treatment of deep endometriosis: uptake of lipid core nanoparticles by LDL receptors in endometriotic foci